β2-adrenoceptor genotype and function affect hemodynamic profile heterogeneity in postural tachycardia syndrome

Hypertension

Volumn 47, Issue 3, 2006, Pages 421-427

  Jacob, Giris ^a   Garland, Emily M ^b   Costa, Fernando ^a   Michael Stein, C ^a,b   Xie, Hong Guang ^b   Robertson, Rose Marie ^b   Biaggioni, Italo ^b   Robertson, David ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptor agonists; Norepinephrine; Polymorphism; Receptors; Tachycardia

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; DNA; ISOPRENALINE; NORADRENALIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; GLYCINE;

ADRENALIN BLOOD LEVEL; ADULT; AGE DISTRIBUTION; ARTICLE; BLURRED VISION; BODY MASS; CODON; CONTROLLED STUDY; DEMOGRAPHY; DIZZINESS; DOSE RESPONSE; FATIGUE; FEMALE; FOREARM BLOOD FLOW; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEADACHE; HEMODYNAMICS; HUMAN; IRRITABILITY; LEG BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; NAUSEA; NORADRENALIN BLOOD LEVEL; POSTURAL TACHYCARDIA SYNDROME; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SEX RATIO; STANDING; STATISTICAL ANALYSIS; SUPINE POSITION; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA; VASODILATATION; ARTERY; BLOOD; BODY POSTURE; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME;

ADRENERGIC BETA-AGONISTS; ADULT; ARTERIES; CATECHOLAMINES; CODON; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; GLUTAMIC ACID; GLYCINE; HEMODYNAMIC PROCESSES; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTURE; RECEPTORS, ADRENERGIC, BETA-2; SYNDROME; TACHYCARDIA; VASODILATION;

EID: 33644987566     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000205120.46149.34     Document Type: Article

References (36)

1. Schondorf R, Low PA. Idiopathic postural tachycardia syndrome. Neurology. 1993;43:132-137.
2. Jacob G, Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci. 1999;317:88-101.
3. Farquhar WB, Taylor JA, Darling SE, Chase KP, Freeman R. Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation. 2000;102:3086-3091.
4. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343:1008-1014.
5. Jacob G, Robertson D, Mosqueda-Garcia R, Ertl CA, Robertson RM, Biaggioni I. Hypovolemia in syncope and orthostatic intolerance: Role of renin-angitensin system. Am J Med. 1997;103:128-133.
6. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847-855.
7. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342:541-549.
8. Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation. 1999;99:1706-1712.
9. Singer W, Shen WK, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Low PA. Evidence of an intrinsic sinus node abnormality in patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77:246-252.
10. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ. The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med. 2001;345:1030-1035.
11. Goldstein DS, Eisenhofer G, Stuff R. Plasma dihydroxyphenylglycerol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest. 1988;81:231-240.
12. Raine NM, Sneddon JC. A simple water-filled plethysmograph for measurement of limb blood flow in humans. Adv Physiol Educ. 2002;26:120-128.
13. Dewar JC, Wheatley AP, Venn A, Morrison JF, Britton J, Hall IP. β2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clinical & Experimental Allergy. 1998;28:442-448.
14. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, Gainer JV, Brown NJ, Haines JL, Wood AJ. Frequency of functionally important β-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics. 1999;9:511-516.
15. Rowell LB. Human Cardiovascular Control. New York: Oxford; 1993.
16. Stewart JM, Montgomery LD. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2004;287:H1319-H1327.
17. Stewart JM, Medow MS, Montgomery LD. Local vascular responses affecting blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2003;285:H2749-H2756.
18. Fouad FM, Thadena-Thome L, Bravo E, Tarazi RC. Idiopathic hypovolemia. Ann Int Med. 1986;298-303.
19. Medow MS, Minson CT, Stewart JM. Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation. 2005;112:2611-2618.
20. Goldstein DS, Eldadah B, Holmes C, Pechnik S, Moak J, Sharabi Y. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation. 2005;111:839-845.
21. Hoffman BB. Catecholamines, symapthomimetic drugs, and adrenergic receptor antagonists. In: Hrdaman JG, Limberd LL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2001.
22. Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, De Luca G, Iaccarino G, De Bruyne B, Chiariello M, Wijns W. Role of β2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation. 2005;111:288-294.
23. Rascado RR, Bendhack LM. Activation of α(2)-adrenoceptors is necessary to induce nitric oxide release in isoprenaline-induced relaxation. Vascul Pharmacol. 2005;42:63-68.
24. Whalen EJ, Johnson AK, Lewis SJ. β-adrenoceptor dysfunction after inhibition of NO synthesis. Hypertension. 2000;36:376-382.
25. Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D. Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension. 2002;39:173-178.
26. Insel PA. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors-evolving concepts and clinical implications. N Engl J Med. 1996;334:580-585.
27. Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP. β(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 2000;36:371-375.
28. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F. β-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension. 1999;33:1425-1430.
29. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB. β2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J. 2000;139:537-542.
30. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E. Positional genomic analysis identifies the β(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation. 2000;101:2877-2882.
31. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the β 2-adrenergic receptor in normal and asthmatic subjects. Am Journal of Respiratory Cell & Molecular Biology. 1993;8:334-339.
32. Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clinical Pharmacology & Therapeutics. 1999;65:519-525.
33. Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE. β2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension. 2003;42:685-692.
34. Schondorf R. Evaluation of the patient with orthostatic intolerance. In: Robertson D, ed. Primer on the Autonomic Nervous System. Amsterdam, The Netherlands: Elsevier; 2004.
35. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJ. Forearm β adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest. 1995;96:579-585.
36. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation. 1997;96:575-580.